Showing results (1041-1050 of 1,119) with videos related to
Sort By:
Pageof 112
Journal of the American College of Cardiology|July 11, 2020
Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCIGuillaume Marquis-Gravel, Frederik Dalgaard, Aaron D Jones, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 8, 2021
Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Alaide Chieffo, Giuseppe Tarantini, Christoph Kurt Naber, et al.Neuromuscular Disorders : NMD|June 29, 2025
Levels of exercise exposure among people living with neuromuscular disorders: lessons learned from real-world dataMark Richardson, Virginie Kinet, Karen Wong, et al.Lancet (London, England)|September 6, 2019
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trialDeepak L Bhatt, Philippe Gabriel Steg, Shamir R Mehta, et al.Muscle & Nerve|May 4, 2022
Comparison of strength testing modalities in dysferlinopathyNatalie F Reash, Meredith K James, Lindsay N Alfano, et al.Journal of the American College of Cardiology|March 11, 2022
5-Year Outcomes of PCI Guided by Measurement of Instantaneous Wave-Free Ratio Versus Fractional Flow ReserveMatthias Götberg, Karolina Berntorp, Rebecca Rylance, et al.Circulation|June 23, 2025
Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II SubstudyPernille G Thrane, Michael Maeng, Akiko Maehara, et al.Journal of the American College of Cardiology|February 25, 2014
Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trialKenneth W Mahaffey, Claes Held, Daniel M Wojdyla, et al.Journal of Medicinal Chemistry|August 15, 1997
Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonistsB R Henke, C J Aquino, L S Birkemo, et al.Elife|May 16, 2024
Long-term hematopoietic transfer of the anti-cancer and lifespan-extending capabilities of a genetically engineered blood system by transplantation of bone marrow mononuclear cellsJing-Ping Wang, Chun-Hao Hung, Yae-Huei Liou, et al.Pageof 112